+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Recombinant Human Fibroblast Growth Factor Market - Global Forecast 2025-2030- Product Image
Recombinant Human Fibroblast Growth Factor Market - Global Forecast 2025-2030- Product Image
Sale

Recombinant Human Fibroblast Growth Factor Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6130980
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Recombinant human fibroblast growth factors (rhFGF) are reshaping regenerative medicine and cosmetic therapeutics by enabling reliable, scalable biologic production. This market continues to accelerate as advanced expression platforms and process controls drive adoption across pharmaceutical and personal care sectors.

Market Snapshot: Recombinant Human Fibroblast Growth Factor

The recombinant human fibroblast growth factor market is experiencing robust expansion, propelled by scientific innovation and expanding applications in therapy and personal care. Bioengineered fibroblast growth factors underpin cutting-edge solutions across wound healing, tissue engineering, and research. Strategic investments in both mammalian and microbial expression systems have enhanced production efficiency and protein activity consistency. Leaders in biotechnology and pharmaceuticals increasingly rely on these growth factors for new therapeutics and high-value formulations, while evolving regulatory frameworks accommodate emerging biologics standards. Increasing cross-sector collaborations and advanced purification techniques strengthen the global supply chain, supporting broader clinical and commercial integration.

Scope & Segmentation

  • Product Types: FGF-1 and FGF-2 for research pipelines and early-stage therapies; FGF-7, FGF-10, and FGF-21 targeting regenerative medicine and metabolic studies.
  • Applications:
    • Anti-aging creams and hair growth serums in cosmetics.
    • Research use in academic and industrial labs focusing on mechanistic evaluation and scale-up.
    • Tissue engineering protocols for cell therapy and scaffolds.
    • Wound healing in burns, diabetic ulcers, and surgical wound recovery.
  • End Users:
    • Cosmetic product developers.
    • Pharmaceutical companies, including biotech innovators and generic manufacturers.
    • Research institutions advancing foundational science.
  • Formulation Types:
    • Lyophilized powders for stable storage.
    • Solutions offered in both single and multi-dose formats tailored for laboratory and clinical workflows.
  • Distribution Channels:
    • E-commerce via direct-to-consumer platforms and third-party marketplaces.
    • Hospital and retail pharmacies providing broad accessibility.
  • Regions:
    • Americas with focus on the United States, Canada, Mexico, Brazil, and Argentina.
    • Europe, Middle East, and Africa encompassing diverse markets such as United Kingdom, Germany, Saudi Arabia, South Africa, and more.
    • Asia-Pacific, including China, India, Japan, Australia, and Southeast Asian markets.
  • Leading Companies:
    • Thermo Fisher Scientific Inc.
    • Bio-Techne Corporation
    • Merck KGaA
    • Lonza Group AG
    • GenScript Biotech Corporation
    • Sino Biological Inc.
    • Creative Biolabs Co., Ltd.
    • Abcam plc
    • Proteintech Group, Inc.
    • Novoprotein Scientific Inc.

Key Takeaways & Competitive Insights

  • Continued adoption of mammalian and yeast expression systems elevates purity and post-translational fidelity, supporting clinical and cosmetic use cases.
  • Advancements in lyophilization and formulation science drive functional stability and enable distribution to global markets under varied storage conditions.
  • Industry partnerships bridge R&D breakthroughs and commercial deployment, expediting translation of FGF variants into clinical studies and therapeutic formulations.
  • Flexible manufacturing and digital monitoring approaches optimize yields and align with evolving quality standards.
  • Strategic moves towards process intensification and cross-regional ventures mitigate supply chain disruptions and support efficient scaling.

Tariff Impact on Supply Chains and Economics

Recent United States tariff policies have reconfigured supply chains for recombinant fibroblast growth factors. Key manufacturing inputs and purification reagents have been affected, prompting producers to optimize sourcing, revise supplier agreements, and consider relocating production to regions with more favorable trade conditions. These shifts catalyze strategic alignments with local contract manufacturers and the diversification of expression systems, minimizing trade-associated disruptions and preserving operational flexibility.

Methodology & Data Sources

This analysis applies a rigorous, multi-phase research approach. Secondary research synthesizes peer-reviewed literature, regulatory updates, and key patents. Primary interviews with industry experts and leaders from biotech firms and contract manufacturers yield qualitative perspective, validated through expert panels and data triangulation. Findings are cross-verified to ensure insight reliability and relevance to strategic planning.

Why This Report Matters

  • Provides comprehensive segmentation and trend analysis across product types, regions, and applications, facilitating targeted investment and strategic planning.
  • Delivers actionable competitive insights to support agile responses to regulatory changes, technological breakthroughs, and trade developments.
  • Enables decision-makers to map the evolving landscape and capture new growth opportunities in recombinant human fibroblast growth factor development.

Conclusion

The recombinant fibroblast growth factor market is defined by innovation, regulatory evolution, and resilient supply chains. Equipped with these insights, stakeholders can drive value creation, inform operational decisions, and shape the future trajectory of regenerative therapeutics and personal care advancements.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing clinical approvals for recombinant human fibroblast growth factor therapies in chronic wound management
5.2. Expansion of biosimilar production capacity driving cost competitiveness in fibroblast growth factor formulations
5.3. Advancements in protein engineering enhancing stability and bioavailability of rhFGF for dermatological applications
5.4. Strategic partnerships between biotech firms and contract manufacturers accelerating rhFGF market entry timelines
5.5. Surge in demand for rhFGF-infused cosmetic products to address anti-aging and skin regeneration needs
5.6. Growing research into combination therapies integrating rhFGF with stem cells for advanced tissue regeneration
5.7. Adoption of continuous manufacturing technologies to improve rhFGF production efficiency and reduce supply bottlenecks
5.8. Increasing investments in automated bioreactor systems to scale up rhFGF synthesis under GMP conditions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Recombinant Human Fibroblast Growth Factor Market, by Product Type
8.1. Introduction
8.2. FGF-1
8.2.1. Expression System
8.2.2. Mammalian
8.2.3. Yeast
8.3. FGF-10
8.4. FGF-2
8.4.1. Expression System
8.4.2. Mammalian
8.4.3. Yeast
8.5. FGF-21
8.6. FGF-7
9. Recombinant Human Fibroblast Growth Factor Market, by Application
9.1. Introduction
9.2. Cosmetics
9.2.1. Anti-Aging Creams
9.2.2. Hair Growth Products
9.3. Research
9.3.1. Academic Research
9.3.2. Industrial Research
9.4. Tissue Engineering
9.4.1. Cell Therapy
9.4.2. Scaffold Development
9.5. Wound Healing
9.5.1. Burns
9.5.2. Diabetic Ulcers
9.5.3. Surgical Wounds
10. Recombinant Human Fibroblast Growth Factor Market, by End User
10.1. Introduction
10.2. Cosmetic Companies
10.3. Pharmaceutical Companies
10.3.1. Biotech Companies
10.3.2. Generic Manufacturers
10.4. Research Institutes
11. Recombinant Human Fibroblast Growth Factor Market, by Form
11.1. Introduction
11.2. Lyophilized Powder
11.3. Solution
11.3.1. Multi Dose
11.3.2. Single Dose
12. Recombinant Human Fibroblast Growth Factor Market, by Distribution Channel
12.1. Introduction
12.2. E-Commerce
12.2.1. Direct To Consumer Platforms
12.2.2. Third Party Marketplaces
12.3. Hospital Pharmacies
12.4. Retail Pharmacies
13. Americas Recombinant Human Fibroblast Growth Factor Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Recombinant Human Fibroblast Growth Factor Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Recombinant Human Fibroblast Growth Factor Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Bio-Techne Corporation
16.3.3. Merck KGaA
16.3.4. Lonza Group AG
16.3.5. GenScript Biotech Corporation
16.3.6. Sino Biological Inc.
16.3.7. Creative Biolabs Co., Ltd.
16.3.8. Abcam plc
16.3.9. Proteintech Group, Inc.
16.3.10. Novoprotein Scientific Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET: RESEARCHAI
FIGURE 26. RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET: RESEARCHSTATISTICS
FIGURE 27. RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET: RESEARCHCONTACTS
FIGURE 28. RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-1, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-1, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY EXPRESSION SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY EXPRESSION SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY MAMMALIAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY YEAST, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY YEAST, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-1, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-1, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-10, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-10, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-2, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-2, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY EXPRESSION SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY EXPRESSION SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY MAMMALIAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY YEAST, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY YEAST, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-2, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-2, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-21, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-21, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-7, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-7, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COSMETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COSMETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY ANTI-AGING CREAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY ANTI-AGING CREAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY HAIR GROWTH PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY HAIR GROWTH PRODUCTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY INDUSTRIAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY INDUSTRIAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY SCAFFOLD DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY SCAFFOLD DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY WOUND HEALING, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY BURNS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY BURNS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY DIABETIC ULCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY DIABETIC ULCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY SURGICAL WOUNDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY SURGICAL WOUNDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COSMETIC COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COSMETIC COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY GENERIC MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY GENERIC MANUFACTURERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY MULTI DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY SINGLE DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY SOLUTION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY E-COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY DIRECT TO CONSUMER PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY DIRECT TO CONSUMER PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY THIRD PARTY MARKETPLACES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY THIRD PARTY MARKETPLACES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-1, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-1, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-2, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-2, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY SOLUTION, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-1, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-1, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-2, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-2, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY SOLUTION, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 173. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-1, 2018-2024 (USD MILLION)
TABLE 176. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-1, 2025-2030 (USD MILLION)
TABLE 177. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-2, 2018-2024 (USD MILLION)
TABLE 178. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-2, 2025-2030 (USD MILLION)
TABLE 179. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 182. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 183. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 184. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 185. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 186. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 187. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 188. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 189. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 192. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 193. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 194. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 195. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
TABLE 196. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY SOLUTION, 2025-2030 (USD MILLION)
TABLE 197. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 200. CANADA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 201. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-1, 2018-2024 (USD MILLION)
TABLE 204. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-1, 2025-2030 (USD MILLION)
TABLE 205. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-2, 2018-2024 (USD MILLION)
TABLE 206. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-2, 2025-2030 (USD MILLION)
TABLE 207. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 210. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 211. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 212. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 213. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 214. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 215. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 216. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 217. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 220. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 221. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 222. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 223. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
TABLE 224. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY SOLUTION, 2025-2030 (USD MILLION)
TABLE 225. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 228. MEXICO RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-1, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-1, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-2, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-2, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY SOLUTION, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-1, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-1, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-2, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FGF-2, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR M

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Recombinant Human Fibroblast Growth Factor market report include:
  • Thermo Fisher Scientific Inc.
  • Bio-Techne Corporation
  • Merck KGaA
  • Lonza Group AG
  • GenScript Biotech Corporation
  • Sino Biological Inc.
  • Creative Biolabs Co., Ltd.
  • Abcam plc
  • Proteintech Group, Inc.
  • Novoprotein Scientific Inc.

Related Topics

Related Reports

Recombinant Human Fibroblast Growth Factor Kit Market - Global Forecast 2025-2030 - Product Image

Recombinant Human Fibroblast Growth Factor Kit Market - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Recombinant Human Basic Fibroblast Growth Factor Market - Global Forecast 2025-2030 - Product Image

Recombinant Human Basic Fibroblast Growth Factor Market - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Fibroblast Growth Factors (FGFs) Global Market Report 2025 - Product Image

Fibroblast Growth Factors (FGFs) Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Fibroblast Growth Factor Reagent Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Fibroblast Growth Factor Reagent Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Fibroblast Growth Factors - Global Strategic Business Report - Product Image

Fibroblast Growth Factors - Global Strategic Business Report

  • Report
  • 486 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.